-
2
-
-
0002733448
-
Benign melanocytic lesions and malignant melanoma
-
Lever W, Lever G eds. Philadelphia, PA: JB Lippincott
-
Lever W, Lever G. Benign melanocytic lesions and malignant melanoma. In: Lever W, Lever G eds. Histopathology of the skin, 7th ed. Philadelphia, PA: JB Lippincott, 1991; pp 756-797.
-
(1991)
Histopathology of the Skin, 7th Ed.
, pp. 756-797
-
-
Lever, W.1
Lever, G.2
-
3
-
-
0027189924
-
The histology and differential diagnosis of Spitz nevus
-
Binder SW, Asnong C, Paul E. The histology and differential diagnosis of Spitz nevus. Semin Diagn Pathol 10:36-46, 1993
-
(1993)
Semin Diagn Pathol
, vol.10
, pp. 36-46
-
-
Binder, S.W.1
Asnong, C.2
Paul, E.3
-
4
-
-
0023936508
-
Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumors: An immunohistochemical study on paraffin sections
-
Gown AM, Vogel AM, Hoak D, et al. Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumors: An immunohistochemical study on paraffin sections. Virchows Arch Pathol Anat 413:17-24,1988.
-
(1988)
Virchows Arch Pathol Anat
, vol.413
, pp. 17-24
-
-
Gown, A.M.1
Vogel, A.M.2
Hoak, D.3
-
5
-
-
0023729735
-
Comparison of HMB-45 monoclonal antibody and S100 protein in the immunohistochemical diagnosis of melanoma
-
Ordonez NG, Xialong J, Mickey RC. Comparison of HMB-45 monoclonal antibody and S100 protein in the immunohistochemical diagnosis of melanoma. Am J Clin Pathol 90:385-390, 1988.
-
(1988)
Am J Clin Pathol
, vol.90
, pp. 385-390
-
-
Ordonez, N.G.1
Xialong, J.2
Mickey, R.C.3
-
7
-
-
0027252828
-
Immunohistochemistry in the evaluation of melanocytic tumors
-
Ruiter DJ, Brocker EB. Immunohistochemistry in the evaluation of melanocytic tumors. Semin Diagn Pathol 10:76-91, 1993.
-
(1993)
Semin Diagn Pathol
, vol.10
, pp. 76-91
-
-
Ruiter, D.J.1
Brocker, E.B.2
-
8
-
-
0024347704
-
HMB45 staining of dysplastic nevi: Support for a spectrum of progression toward melanoma
-
Smoller BR, McNutt NS, Hsu A. HMB45 staining of dysplastic nevi: Support for a spectrum of progression toward melanoma. Am J Surg Pathol 13:680-684, 1989.
-
(1989)
Am J Surg Pathol
, vol.13
, pp. 680-684
-
-
Smoller, B.R.1
McNutt, N.S.2
Hsu, A.3
-
9
-
-
0026341036
-
Expression of mutant p53 in melanoma
-
Strech JR, Gatter KC, Ralfkiaer E, Lane DP, Harris AL. Expression of mutant p53 in melanoma. Cancer Res 51:5976-5979,1991.
-
(1991)
Cancer Res
, vol.51
, pp. 5976-5979
-
-
Strech, J.R.1
Gatter, K.C.2
Ralfkiaer, E.3
Lane, D.P.4
Harris, A.L.5
-
10
-
-
0025879530
-
Aberrant expression of p53 oncoprotein is a common feature of a wide spectrum of human malignancies
-
Bartek J, Bartkova J, Voilesek B, et al. Aberrant expression of p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6:1699-1703,1991.
-
(1991)
Oncogene
, vol.6
, pp. 1699-1703
-
-
Bartek, J.1
Bartkova, J.2
Voilesek, B.3
-
11
-
-
0027243889
-
P53 protein expression in nevi and melanomas
-
Cristofolini M, Boi S, Girlando S, et al. p53 protein expression in nevi and melanomas. Arch Dermatol 129:739-743, 1993.
-
(1993)
Arch Dermatol
, vol.129
, pp. 739-743
-
-
Cristofolini, M.1
Boi, S.2
Girlando, S.3
-
12
-
-
33749836075
-
Correlation of tumor proliferative activity and p53 expression with tumor progress and survival in malignant melanoma
-
Stone H, Lynch EF, Linden JK, et al. Correlation of tumor proliferative activity and p53 expression with tumor progress and survival in malignant melanoma. Am J Clin Pathol 50A:275, 1994.
-
(1994)
Am J Clin Pathol
, vol.50 A
, pp. 275
-
-
Stone, H.1
Lynch, E.F.2
Linden, J.K.3
-
13
-
-
33749853433
-
Evaluation of -53, Ki-67 and PCNA content as prognostic indicators in primary cutaneous and metastatic melanoma
-
Modzelewski R JR, Park HK, Raso DS, et al. Evaluation of -53, Ki-67 and PCNA content as prognostic indicators in primary cutaneous and metastatic melanoma. Am J Clin Pathol 48A:263, 1994.
-
(1994)
Am J Clin Pathol
, vol.48 A
, pp. 263
-
-
Modzelewski, R.J.R.1
Park, H.K.2
Raso, D.S.3
-
14
-
-
0027383982
-
Immunohistochemical study of Spitz nevi and malignant melanoma with use of antibody to proliferating cell nuclear antigen
-
Niemann TH, Argenyi ZB. Immunohistochemical study of Spitz nevi and malignant melanoma with use of antibody to proliferating cell nuclear antigen. Am J Dermatopathol 15:441445, 1993.
-
(1993)
Am J Dermatopathol
, vol.15
, pp. 441-445
-
-
Niemann, T.H.1
Argenyi, Z.B.2
-
15
-
-
0026065163
-
Determination of proliferating fractions in malignant melanoma by anti-PCNA/cyclin monoclonal antibody
-
Takahashi H, Strutton GM, Parasons PG. Determination of proliferating fractions in malignant melanoma by anti-PCNA/cyclin monoclonal antibody. Histopathology 18:221-227, 1991.
-
(1991)
Histopathology
, vol.18
, pp. 221-227
-
-
Takahashi, H.1
Strutton, G.M.2
Parasons, P.G.3
-
16
-
-
33749869368
-
Cell proliferation marker in predicting outcome in malignant melanoma
-
Reddy V, Aranha G, Ptocki D, et al. Cell proliferation marker in predicting outcome in malignant melanoma. Am J Clin Pathol 48A:266, 1994.
-
(1994)
Am J Clin Pathol
, vol.48
, pp. 266
-
-
Reddy, V.1
Aranha, G.2
Ptocki, D.3
-
17
-
-
33749853759
-
Immunohistochemical study with antibody to PCNA antigen and EFGR in malignant melanoma of external ear
-
in 1993, Poster #12. Abstract published in Proceedings
-
Ronan SG, Farolan M, Hjeiken T, et al. Immunohistochemical study with antibody to PCNA antigen and EFGR in malignant melanoma of external ear. Presented at Annual American Soc of Dermatopathol Meeting in 1993, Poster #12. Abstract published in Proceedings p145.
-
Annual American Soc of Dermatopathol Meeting
, pp. 145
-
-
Ronan, S.G.1
Farolan, M.2
Hjeiken, T.3
-
18
-
-
0025836848
-
The initial steps of tumor progression in melanocytic lineage: A histochemical approach
-
Wollina U, Kilian U, Henkel U, et al. The initial steps of tumor progression in melanocytic lineage: A histochemical approach. Anticancer Res 11:1405-1414, 1991.
-
(1991)
Anticancer Res
, vol.11
, pp. 1405-1414
-
-
Wollina, U.1
Kilian, U.2
Henkel, U.3
-
19
-
-
33749849074
-
Ki67 expression and nuclear organizer regions in progressively dysplastic melanocytic lesions
-
Fogt F, Vortmeyer AO, Tahan SR. Ki67 expression and nuclear organizer regions in progressively dysplastic melanocytic lesions. Am J Clin Pathol 46A:251, 1994.
-
(1994)
Am J Clin Pathol
, vol.46 A
, pp. 251
-
-
Fogt, F.1
Vortmeyer, A.O.2
Tahan, S.R.3
-
20
-
-
33749848480
-
MIB-1-proliferative activity is a significant indicator of survival in primary thick cutaneous melanoma
-
Kahn HJ, Ramsay JA, From L, et al. MIB-1-proliferative activity is a significant indicator of survival in primary thick cutaneous melanoma. Am J Clin Pathol 6A:255, 1994.
-
(1994)
Am J Clin Pathol
, vol.6 A
, pp. 255
-
-
Kahn, H.J.1
Ramsay, J.A.2
From, L.3
-
21
-
-
33749848179
-
MIB-1 (Ki-67) determined tumor proliferation in adult Spitz nevi: Comparison with similar depth malignant melanomas
-
Stone CH, Ma C, Linden MD, et al. MIB-1 (Ki-67) determined tumor proliferation in adult Spitz nevi: Comparison with similar depth malignant melanomas. Am J Clin Pathol 50A:76, 1994.
-
(1994)
Am J Clin Pathol
, vol.50 A
, pp. 76
-
-
Stone, C.H.1
Ma, C.2
Linden, M.D.3
|